Effects of Safety-Related Alerts on Aliskiren Use Trends: An Observational Study from Portugal

Bibliographic Details
Main Author: Teixeira Rodrigues, António
Publication Date: 2014
Other Authors: Silva, Tânia, Roque, Fátima, Figueiras, A, Herdeiro, Maria Teresa
Format: Article
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10314/3273
https://doi.org/DOI: http://dx.doi.org/10.1016/j.clinthera.2014.05.057
Summary: Drug safety profile is not fully known before marketing authorization and the publication of aliskiren safety-related alerts (SA) could have clinical and economic consequences. This study sought to assess the impact of aliskiren SA on consumption trends of all medicines containing aliskiren available in Portugal.
id RCAP_cdb28f2efdd2b96f9e80f4f70dd6b3b7
oai_identifier_str oai:bdigital.ipg.pt:10314/3273
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Effects of Safety-Related Alerts on Aliskiren Use Trends: An Observational Study from Portugalsafety alertsaliskirensale trendsDrug safety profile is not fully known before marketing authorization and the publication of aliskiren safety-related alerts (SA) could have clinical and economic consequences. This study sought to assess the impact of aliskiren SA on consumption trends of all medicines containing aliskiren available in Portugal.Clinical Therapeutics (Elsevier)2016-11-19T04:46:04Z2016-11-192014-08-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10314/3273https://doi.org/DOI: http://dx.doi.org/10.1016/j.clinthera.2014.05.057http://hdl.handle.net/10314/3273engTeixeira Rodrigues, AntónioSilva, TâniaRoque, FátimaFigueiras, AHerdeiro, Maria Teresainfo:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-01-05T02:58:54Zoai:bdigital.ipg.pt:10314/3273Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T19:24:10.508583Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Effects of Safety-Related Alerts on Aliskiren Use Trends: An Observational Study from Portugal
title Effects of Safety-Related Alerts on Aliskiren Use Trends: An Observational Study from Portugal
spellingShingle Effects of Safety-Related Alerts on Aliskiren Use Trends: An Observational Study from Portugal
Teixeira Rodrigues, António
safety alerts
aliskiren
sale trends
title_short Effects of Safety-Related Alerts on Aliskiren Use Trends: An Observational Study from Portugal
title_full Effects of Safety-Related Alerts on Aliskiren Use Trends: An Observational Study from Portugal
title_fullStr Effects of Safety-Related Alerts on Aliskiren Use Trends: An Observational Study from Portugal
title_full_unstemmed Effects of Safety-Related Alerts on Aliskiren Use Trends: An Observational Study from Portugal
title_sort Effects of Safety-Related Alerts on Aliskiren Use Trends: An Observational Study from Portugal
author Teixeira Rodrigues, António
author_facet Teixeira Rodrigues, António
Silva, Tânia
Roque, Fátima
Figueiras, A
Herdeiro, Maria Teresa
author_role author
author2 Silva, Tânia
Roque, Fátima
Figueiras, A
Herdeiro, Maria Teresa
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Teixeira Rodrigues, António
Silva, Tânia
Roque, Fátima
Figueiras, A
Herdeiro, Maria Teresa
dc.subject.por.fl_str_mv safety alerts
aliskiren
sale trends
topic safety alerts
aliskiren
sale trends
description Drug safety profile is not fully known before marketing authorization and the publication of aliskiren safety-related alerts (SA) could have clinical and economic consequences. This study sought to assess the impact of aliskiren SA on consumption trends of all medicines containing aliskiren available in Portugal.
publishDate 2014
dc.date.none.fl_str_mv 2014-08-01T00:00:00Z
2016-11-19T04:46:04Z
2016-11-19
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10314/3273
https://doi.org/DOI: http://dx.doi.org/10.1016/j.clinthera.2014.05.057
http://hdl.handle.net/10314/3273
url http://hdl.handle.net/10314/3273
https://doi.org/DOI: http://dx.doi.org/10.1016/j.clinthera.2014.05.057
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Clinical Therapeutics (Elsevier)
publisher.none.fl_str_mv Clinical Therapeutics (Elsevier)
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833598073767460864

Similar Items